Brief: Bone Therapeutics Reaches 50% Treated Patients In JTA-004 Phase III Study

Biosenic SA

20/10/2020 06:08

Oct 20 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS REACHES 50% TREATED PATIENTS IN
ONGOING
JTA-004 PHASE III PIVOTAL KNEE OSTEOARTHRITIS STUDY
    * TOPLINE RESULTS ARE ANTICIPATED ON 3-MONTH PRIMARY
ENDPOINT AND
6-MONTH FOLLOW-UP PERIOD IN SECOND HALF OF 2021.
    * BONE THERAPEUTICS EXPECTS TO COMPLETE PATIENT ENROLLMENT
BEFORE
YEAR-END

Source text for Eikon:  ID:nGNEbT1g63 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))